to Thanks, your alternatives sentiment position with in on of a eye exit I core the want echo review with strategic businesses. an towards excitement healthcare executing Mike. first process about our strength discipline to our
XXXX our me Let results. share year second fiscal quarter first
segment, member revenue administrative revenue from mid-XX% was for to as level. in increase impacted business. a profitability our expected, meet managing year of as actively fee by net fees and prior declined expectations the blended result total aggregate In the ongoing share discipline our an our While did net period, Chain the Supply in we Services
current in continue This customers' in and in inventory revenue. market members purchasing. lower period, impact products impact a by In excess and which resulting direct the partially was levels, decline of offset and to sourcing to has experience other pricing supply we our the business, in year continued contributed member demand growth
operational provide more resiliency chain. some to the I care health moving supply Before on create in wanted updates our to on, strategies
domestic year. our of products near earlier manufacturing part and As on manufacturing to bring in initiatives began partner Tennessee producing this more shore, gown our
domestic In addition, the in expect XXXX. glove of launch second to we fiscal program half our
offers which X Services members period. added access decrease our in revenue program, to agreements the a to we contributions from segment, to by compared medications short was our impacted Performance in now drugs resiliency Lastly, over enterprise prior license drug additional XXX supply. In vital year shortage
our market that the validate solutions. about for need we remain opportunities enthusiastic However,
For example, we consulting margin leveraging and care our clinical providers as health growth in improvement. drive to continue Premier services to are drive business
also grew continue our aggregate. TFS with progress accelerate through AI over XX% make trials. We adjacent Applied businesses, partnership announced our evidence clinical innovative markets into Science, in in Premier's business, where to integrate research recently ways which our real-world Notably, will help in Sciences we to Health
seeing Henry has for eliminated reported manual Premier's X-month handling Ford money. period. need our payables that continue solutions margin to In considerable invoicing over validation nearly and the providers paper of platform invoices addition, we are and Recently, Health technology-enabled market that time XXX,XXX improvement save a digital
was EBITDA by profitability. the income to GAAP factors. the following net Turning $XX.X quarter. Total million for was impacted adjusted
Chain Services in businesses. and mainly businesses. due to Supply adjusted an And decreased second, and support in adjacent Performance in due adjusted a EBITDA lower and EBITDA incremental consulting revenue and services support of declined GPO our markets First, to increase headcount in mainly to expenses our Services growth comanagement supply revenue decrease chain
liquidity The for XXXX months flow sheet direct adjusted a driven year business prior primarily This to declined higher decrease was the period. decreased from compared EBITDA. and partially factors adjusted offset earnings same million the and due costs logistics partially $XXX.X fiscal income year Adjusted lower prior perspective, profit sourcing and in balance the were of of operations higher margin From by million the in offset impacted that net X share first a to decreases product cash income. from by period. $XX.X per by each our interest
sale performance-related lower primarily payments of change quarter purchases during by XXXX reduction lower compared The million the operations. revenue tax was current prior due fiscal the year Cash non-health in from our in payments GPO XXXX care period. in the and by payments was net compensation fiscal to offset was lesser impacted period to in the partially to a the fiscal a $XXX.X year inventory and extent first
of aforementioned million the tax cash purchases that Free operations, increase cash the the first same software $XX.X payments $XXX.X to automation. in decreased an flow advancement inflow in fiscal factors an capitalized supply period, technology X impacted as primarily $XXX.X in related for of of million our year the from to as prior well from flow months million outflow XXXX, an of the including chain due
our approximate as and $XX.X XX% to Looking forward tax related the of of of payments sale flow operations, to as XX, million XX% of cash GPO care million we with cash XXXX, EBITDA the non-health impact year. and to totaled June for XXXX. excluding Cash $XXX.X December compared of free XXXX full adjusted XX, fiscal expect the equivalents
driven operations, care non-health our tax the the of The was increase previously sale net of mentioned by payments. GPO
to up we work consent XX, December have $XXX in the continue we true-up a we ends purchase final million as As February. the and in to $XXX.X a through total period price be of of now expect that million member and to proceeds, received
used to will have focused outstanding approach. these to disciplined quarter. a of As continue net X-year deployment, With credit our balance we to stated portion quarter, last remain of the proceeds and respect second pay balanced as billion end on no $X facility revolving of the capital down we we taking and a
fiscal billion Board Mike transaction. a will a the As new our which X $XXX implementation including cash XXXX. XXXX, repurchase to authorization months has through stockholders, $XX.X during dividend, accelerate million approved share This our the returns of XX, accelerated $X first June augment share to quarterly mentioned, of totaled million, repurchase
Board of share of In as addition, of per XX, a record recently X. declared XXXX, payable March on our to $X.XX dividend stockholders March
enhance offerings We in growth opportunities organic acquisitions also to strengthen, differentiate our complement the will and in invest evaluate capabilities and existing to marketplace. our continue to potential or
remainder outlook our to Turning the of for the year.
alternatives result are our formal strategic fiscal we providing of conclusion guidance. the XXXX a process, of As now review
market key significant and the impact incorporate repurchases we or to business assumptions incorporates any share or repurchase may of it related undertake. guidance transaction not $XXX any Our that the future million does accelerated the share following and divestitures certain acquisitions our
ranges $XXX and Products With $XXX comprised $XXX net in specific fiscal $XXX guidance Services to fees revenue mind, these XXXX support to assumptions our million million. million $XXX full are million up $XX administrative other revenue segment $XXX year follows: million as and of $XX to revenue Supply Direct of to million, Chain services of million, license, million revenue software, Sourcing key of
of segment of Performance $XXX million to these million. $X.XXX billion revenue $XXX billion. to net produced total revenue Together, $X.XXX net Services
of includes million adjusted and $X.XX range the to in the an be per the in $XXX to $XXX to EBITDA repurchase $X.XX, to estimated adjusted share be of earnings $X.XX million, $XXX share impact range accelerated from expect to $X.XX transaction. million We which
further guidance following GPO growth full penetration a of on In the year also business, by anticipate blended based we our mid-XX% continued expect be is spend. member fiscal And will assumptions members basis. fee expectations. continue XXXX member aggregate existing and in share to on for Our the purchasing range in driven we
In expect, than GPO participation stable addition, higher low patient with that flat or we expectations. our of these could or represent but for potential the growth generally more reached in remains assuming business. to tailwinds to we are sourcing quarterly single-digit rate or that In our our products end our lower direct the have business, normalized run finally we extent we utilization this lower member are -- utilization believe headwinds to
nominal we revenue fiscal and expect as to half domestic realized the improvement As to of gown quarterly and continue incremental on normalize, glove our basis XXXX. ramp a second from a contributions and flat of we the pricing ongoing in products result, demand in initiatives sequential
life adjacent fiscal to we aggregate markets markets revenue around XX% revenue approximately Performance and our Contigo clinical XXXX. in represented Services decision Health, businesses. sciences, our in support, With Health adjacent revenue business, In our respect growth anticipate comprised Remintra contributions our of of Contigo of XX%
and the between with enterprise revenue approximately Contigo growth arrangements, Due Consistent timing certain be to quarters. in periodic fiscal consulting and of higher our agreements year, may will license we businesses, profitability years, the of expect X/X other with of magnitude and aggregate of certain recognition of revenue these adjacent adjacent to due prior a XXXX. there combination represent growth our in markets variability this slower engagements markets the in Health associated and
confident of opportunities and our to ahead. committed disciplined strategy remain and in we the creation the value execution closing, In
encouraged customers. to customer share our engagements strategy recent We and by to are existing projects and are and and value excited proposition continue new with
us to We capital ability which balance strong a foundation, continue return by to flexible future provides significant continue operate flow also investing growth. while a financial supported to and sheet, stockholders with the to cash
call We for and appreciate your today, the time open now we'll questions.